FDA Positions Against Homeopathy – Your Health, Your Choice!

By / 19th February, 2018 / No Comments

The FDA is positioning itself to be able to impose action on Homeopathy, but it is not actually proposing those actions at this stage. How are they positioning themselves? By removing the CPG 400.400.

This is a critical document that has guided the FDA on how they enforce Homeopathic regulations, and the FDA is saying that it will withdraw this document as soon as the final guidance comes out …and by doing so, they liberate themselves from what has been a clear line of enforcement principles in the regulation of homeopathy. We need to nip this in the bud!

Our time is limited, and we need your help.  We have until March 15, 2018 to submit comments to the FDA.

The FDA’s prejudiced actions could make a mess out of the Homeopathic industry.

Find your voice!

Find your power!

This is a time sensitive issue as the FDA has opened up a public comment period, which closes March 15, 2018

As of December 2017, the FDA is currently introducing new draft guidance for “Drug Products Labeled as Homeopathic” that announces the FDA’s intent to completely withdraw the Compliance Policy Guide (CPG) 400.400.

This is reckless and unwise because now the Homeopathic industry would no longer have a clear set of compliance guidelines and would be subject to arbitrary enforcement actions by the FDA, at the sole discretion of it’s deputies. This could set dangerous precedent, limiting the rights of individuals to choose their own appropriate healthcare.

Americans for Homeopathy Choice represents the interest of 6 million citizens, especially Mothers, who use Homeopathy. The letters and documents on our website have been drafted with the help of Homeopaths, educators, and Homeopathic manufacturers. We see this action by the FDA as a danger to our freedom to choose our own health care options. We want to keep our freedom to choose Homeopathy for our families–and limiting our access to Homeopathic medicine can be devastating to this industry.

The FDA should not rescind the CPG 400.400, a guidance that has proven itself effective to both the industry and consumers. We question the intent behind this action and note the inevitable damage it would cause to the Homeopathic industry and our free access to it.

If you are bothered by this proposition, click here to see how you can help.

Leave a Comment